Is once-daily dosing the practical choice for asthma maintenance?

04 Aug 2017

Once-daily dosing with Relvar® Ellipta® provides better symptom control and reduced disease exacerbations in asthma. Dr Celeste Mae L. Campomanes emphasized that with better asthma control, patients would not lose days off from work or school. Moreover, they will be able to control their symptoms without having more exacerbations, which could lead to hospitalization and increased use of antibiotics unnecessarily.

Look out for the Symposium Highlight article on to find out more about the use of 
Relvar® Ellipta®.

Related MIMS Drugs

Editor's Recommendations